A more effective vaccine technology may be on the horizon. In a new study in mice, researchers from the University of ...

An mRNA vaccine with coding sequences for the pre-fusion protein of RSV is in phase 3 trials for approval for vaccination in patients aged 60 years and older. It shows high effectiveness even in ...

One surprising star of the coronavirus pandemic response has been the molecule called mRNA. It's the key ingredient in the Pfizer-BioNTech and Moder ...

Without mRNA, your genetic code wouldn't be used, proteins wouldn't be made, ... On 16 March, using Zhang's sequence, the first mRNA vaccine began its phase one clinical trial.

Several mRNA vaccine trials found a debilitating side effect, and now the Trump administration is cutting funding for more ...

Engineered mRNA has turned cells into tiny biofactories, producing medications to successfully treat an inflammatory skin condition and two types of cancer, according to a new study. The tech ...

The drug, known as mRNA-4157, delivers mRNA coding for up to 34 tumor antigens, and is being tested in combination with Merck’s PD-1 antibody, Keytruda, which strengthens anti-cancer immune ...

These vaccines consist of strands of mRNA that code for specific viral proteins. Say you get a Covid-19 vaccine. ... other than the RNA sequence, remain the same across different vaccines.